These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34310243)

  • 1. Bioanalytical strategies in drug discovery and development.
    Thakur A; Tan Z; Kameyama T; El-Khateeb E; Nagpal S; Malone S; Jamwal R; Nwabufo CK
    Drug Metab Rev; 2021 Aug; 53(3):434-458. PubMed ID: 34310243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioanalytical method development and validation: Critical concepts and strategies.
    Moein MM; El Beqqali A; Abdel-Rehim M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():3-11. PubMed ID: 27720355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution MS in regulated bioanalysis: where are we now and where do we go from here?
    Fung EN; Jemal M; Aubry AF
    Bioanalysis; 2013 May; 5(10):1277-84. PubMed ID: 23721448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inductively coupled plasma-MS in drug development: bioanalytical aspects and applications.
    van Heuveln F; Meijering H; Wieling J
    Bioanalysis; 2012 Aug; 4(15):1933-65. PubMed ID: 22943623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery.
    Ackermann BL; Berna MJ; Murphy AT
    Curr Top Med Chem; 2002 Jan; 2(1):53-66. PubMed ID: 11899065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS bioanalysis of intact proteins and peptides.
    Kang L; Weng N; Jian W
    Biomed Chromatogr; 2020 Jan; 34(1):e4633. PubMed ID: 31257628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS systems for quantitative bioanalysis.
    van Dongen WD; Niessen WM
    Bioanalysis; 2012 Oct; 4(19):2391-9. PubMed ID: 23088465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent development in software and automation tools for high-throughput discovery bioanalysis.
    Shou WZ; Zhang J
    Bioanalysis; 2012 May; 4(9):1097-109. PubMed ID: 22612689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioanalytical LC-MS of therapeutic oligonucleotides.
    van Dongen WD; Niessen WM
    Bioanalysis; 2011 Mar; 3(5):541-64. PubMed ID: 21388267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated quantitative and qualitative workflow for in vivo bioanalytical support in drug discovery using hybrid Q-TOF-MS.
    Ranasinghe A; Ramanathan R; Jemal M; D'Arienzo CJ; Humphreys WG; Olah TV
    Bioanalysis; 2012 Mar; 4(5):511-28. PubMed ID: 22409550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incurred sample reanalysis in drug discovery bioanalysis.
    Giri P; Patel N; Joshi V; Giri S; Srinivas NR
    Biomed Chromatogr; 2019 Mar; 33(3):e4430. PubMed ID: 30412644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspective on high-throughput bioanalysis to support
    Santiago BG; Eisennagel SH; Peckham GE; Liebhardt AM; Alburn CL; Roethke TJ; Reilly MA; Sydor JR; Karlinsey MZ
    Bioanalysis; 2023 Feb; 15(3):177-191. PubMed ID: 36917553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioanalysis in drug discovery and development.
    Pandey S; Pandey P; Tiwari G; Tiwari R
    Pharm Methods; 2010 Oct; 1(1):14-24. PubMed ID: 23781412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography coupled with tandem mass spectrometry for the bioanalysis of proteins in drug development: practical considerations in assay development and validation.
    Liu G; Ji QC; Dodge R; Sun H; Shuster D; Zhao Q; Arnold M
    J Chromatogr A; 2013 Apr; 1284():155-62. PubMed ID: 23466204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted quantitative bioanalysis in plasma using liquid chromatography/high-resolution accurate mass spectrometry: an evaluation of global selectivity as a function of mass resolving power and extraction window, with comparison of centroid and profile modes.
    Xia YQ; Lau J; Olah T; Jemal M
    Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2863-78. PubMed ID: 21913265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for improving the quantitative bioanalytical performance of LC-MS in pharmacokinetic studies.
    Li L; Tian D; Chen F; Yang J; Yu K; Sun Y
    Curr Drug Metab; 2012 Nov; 13(9):1206-12. PubMed ID: 22519367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker Assay Validation by Mass Spectrometry.
    Fernández-Metzler C; Ackermann B; Garofolo F; Arnold ME; DeSilva B; Gu H; Laterza O; Mao Y; Rose M; Vazvaei-Smith F; Steenwyk R
    AAPS J; 2022 May; 24(3):66. PubMed ID: 35534647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography-mass spectrometric multiple reaction monitoring-based strategies for expanding targeted profiling towards quantitative metabolomics.
    Guo B; Chen B; Liu A; Zhu W; Yao S
    Curr Drug Metab; 2012 Nov; 13(9):1226-43. PubMed ID: 22519369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.
    Matuszewski BK; Constanzer ML; Chavez-Eng CM
    Anal Chem; 2003 Jul; 75(13):3019-30. PubMed ID: 12964746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous bioanalysis of a phosphate prodrug and its parent compound using a multiplexed LC-MS method.
    Browning MR; Drexler DM; Olah TV; Morgan DG
    Bioanalysis; 2010 Apr; 2(4):745-53. PubMed ID: 21083272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.